VISCHER

Divided between Zurich and Basel and described by clients as having the ‘best reputation for driving biotech deals in Switzerland’, VISCHER’s broad offering spans the full range of corporate issues within the life sciences space, in addition to acting in administrative disputes concerning reimbursement and distribution issues. Stefan Kohler leads the team alongside the ‘outstanding’ Matthias Staehelin. Kohler is a key name for licensing and R&D agreements, in addition to handling both administrative and patent disputes. Staehelin is recommended for his deep knowledge of series financing and fundraising issues, often advising investors and major biotech companies and investors. Christian Wyss is particularly adept at advising on licence terms, and remains a key contact for start-ups, while Vincent Reardon utilises his broad corporate expertise to assist with M&As and IPOs.